Neisseria meningitidis can produce a TolC-like protein needed for secretion of FrpC but not efflux of antimicrobials. We now report that expression of the meningococcal tolC gene in a TolC-deficient strain of Escherichia coli can restore properties of ␣-hemolysis and antimicrobial resistance known to involve efflux pumps.
Neisseria meningitidis can produce a TolC-like protein needed for secretion of FrpC but not efflux of antimicrobials. We now report that expression of the meningococcal tolC gene in a TolC-deficient strain of Escherichia coli can restore properties of ␣-hemolysis and antimicrobial resistance known to involve efflux pumps.
Despite considerable progress in understanding the pathophysiology of invasive meningococcal disease and the contribution of bacterial virulence factors, much remains to be learned. In particular, little definitive information is available regarding virulence factors that Neisseria meningitidis secretes to the extracellular fluid during infection and how they might damage host cells and tissues or modulate inflammatory responses that are protective or damaging. Certain strains of N. meningitidis (8) , but not of the related pathogen Neisseria gonorrhoeae, produce a type I secretion system similar to the HlyB-HlyD-TolC efflux pump of Escherichia coli (29) , known to be important in the extracellular production of ␣-hemolysin (HlyA) (12, 27, 28) . Klee et al. (8) described a DNA island in certain strains of N. meningitidis that contains tandemly linked hylD and tolC genes that we showed (7) are cotranscribed. Wooldridge et al. (29) demonstrated that N. meningitidis contains an unlinked hlyB gene and predicted the presence of a functional HlyB-HlyD-TolC efflux system in N. meningitidis. We (7) recently showed that meningococcal FrpC, which bears amino acid similarity to HlyA (23, 24) , but has unknown biological activity (4) , is secreted by the HlyB-HlyD-TolC efflux pump.
Although N. meningitidis uses TolC in conjunction with HlyB-HlyD for FrpC export (7), as shown previously for its function with the AcrA-AcrB system in E. coli (5), it is not required for efflux of antimicrobials in the meningococcus. Rather, the MtrE proteins of N. meningitidis and N. gonorrhoeae work with the MtrC-MtrD efflux proteins as the outer membrane protein (OMP) channel for export of antimicrobials (3, 7, 17, 21) . The AcrA-AcrB-TolC and MtrC-MtrD-MtrE efflux pumps are structurally and functionally similar (21) . The amino acid similarity between the TolC OMPs possessed by E. coli and N. meningitidis, their similarity to MtrE (3), and the fact that N. meningitidis has two similar OMPs (MtrE and TolC) led us to further investigate the biologic activity of meningococcal TolC. Accordingly, we asked if this protein could functionally replace TolC used by E. coli in its secretion of HlyA and efflux of antimicrobials. Using a complementation strategy, we found that TolC produced by N. meningitidis can participate in both export functions when expressed in E. coli, suggesting that it has the intrinsic ability to interact with components of bacterial efflux pumps that are involved in antimicrobial resistance and toxin secretion.
(A preliminary account of these findings was presented at the 16th International Pathogenic Neisseria Conference, held in Rotterdam, The Netherlands, from 7 to 12 September 2008.)
Bacterial strains, culture conditions, antimicrobial susceptibility testing, and detection of ␣-hemolysis. N. meningitidis strain M7 (7) was the primary meningococcal strain used in this investigation. M7 and genetic derivatives bearing mutations in mtrE or tolC (Table 1) were grown on gonococcal medium base (GC) agar (Difco Laboratories, Detroit, MI) or GCB broth containing defined supplements I and II (2) at 37°C under 3.8% (vol/vol) CO 2 as described previously (6) . The construction of the M7tolC::Kan strain was previously described (7) . Isogenic E. coli strains MC4100 and RAM1129 were kindly provided by R. Misra (1) and were grown on Luria-Bertani (LB) agar plates at 37°C. The susceptibility of bacterial strains to a panel of antimicrobials (azithromycin, ciprofloxacin, crystal violet, ethidium bromide, novobiocin, palmitic acid, and Triton X-100) was determined by the agar dilution method (6); all chemicals were purchased from Sigma Biochemical (St. Louis, MO). Bacterial susceptibility to the human cathelicidin LL-37 was determined as described by Shafer et al. (20) ; LL-37 was kindly provided by J. Pohl (Emory University). Results from antimicrobial susceptibility tests are reported as MICs, and all experiments were repeated at least three times. The alpha-hemolytic activity of E. coli strains due to extracellular production of HlyA (1, 25, 28) was determined using sheep blood agar plates, which were purchased from Becton, Dickinson and Company (Franklin Lakes, NJ).
Expression of meningococcal tolC and mtrE in E. coli and mutagenesis of mtrE. pNK1 bearing a cloned N. meningitidis tolC gene behind an isopropyl ␤-D-1-thiogalactopyranoside (IPTG)-inducible lacZ promoter in pGCC4 (22) has been described previously (7) . pGCC4 and pNK1 were introduced into E. coli strains MC4100 and RAM1129 by electroporation, and transformants were selected on LB agar containing erythromycin (300 g/ml for MC4100 and 5 g/ml for RAM1129). The mtrE gene was PCR amplified from chromosomal DNA of N. meningitidis strain MC58 by using primers mtrE2 (5Ј-CCTTT GCATTGTCTGCCTGCAC-3Ј) and mtrE5 (5Ј-AAAGGCGG ATTGGACGGCGG-3Ј). The 1,082-bp PCR product was purified and cloned into pBAD by following the manufacturer's protocol (Invitrogen, Carlsbad, CA). Transformants of E. coli strain TOP10 were selected on LB agar containing 100 g/ml of ampicillin. The resulting plasmid construct (pNK2) was then purified from a transformant and digested with NaeI, which recognizes a unique site within mtrE. The omega cassette, encoding resistance to both spectinomycin (Spc) and streptomycin (10), was digested from plasmid pHP45 (15) and ligated into pBAD::mtrE, which had been digested with NaeI to give pNK3. pNK3 was used to transform strain M7, and transformants were selected on GC agar plates containing 60 g/ml of Spc. Spc-resistant transformants containing mtrE::Spc were verified by PCR. DNA from strain M7mtrE::Spc was then used to transform strain M7tolC::Kan (7) to create strain M7tolC::Kan mtrE::Spc.
Functional activities of the N. meningitidis TolC protein. We previously reported that the meningococcal TolC-like OMP, which is similar (26% identity) to the MtrE OMP used by the mtrCDE-encoded efflux pumps in N. gonorrhoeae (6) and N. meningitidis (17) to export hydrophobic antimicrobials, is required for secretion of FrpC but is not required for antimicrobial resistance mediated by the MtrC-MtrD-MtrE efflux pump (7) . In order to determine if meningococcal TolC participates in antimicrobial resistance that is mediated by other efflux pumps produced by N. meningitidis or N. gonorrhoeae, we examined the susceptibility of transformants of strain M7 that contained insertional mutations in mtrE, tolC, or both to substrates of the FarA-FarB (11), MacA-MacB (18), NorM (16), or MtrC-MtrD-MtrE (6) efflux pumps. We found ( Table 1) that loss of mtrE, but not tolC, increased N. meningitidis susceptibility to substrates of the FarA-FarB (palmitic acid), MacA-MacB (azithromycin), or MtrC-MtrD-MtrE (azithromycin, ethidum bromide, and LL-37) efflux pumps; neither mutation affected N. meningitidis susceptibility to a substrate (ciprofloxacin) of the NorM pump. Thus, in agreement with our earlier study (7), the TolC OMP produced by N. meningitidis is not required for meningococcal resistance to antimicrobials mediated by the repertoire of efflux pumps possessed by this pathogen (19, 21) .
The mechanisms by which antimicrobials and ␣-hemolysin (HlyA) are actively secreted by E. coli have been the subject of many investigations, and considerable progress has been made. The AcrA-AcrB efflux system of E. coli is composed of the resistance/nodulation/division transporter protein (AcrB), located in the inner membrane of the bacterium, and a periplasmic membrane fusion protein, AcrA (5, 14) . AcrAB, together with the outer membrane protein TolC, forms a transenvelope structure allowing for the export of certain drugs, dyes, and detergents or detergent-like compounds (13, 14) . HlyA secretion is believed to occur after the mature HlyA interacts with a preformed HlyB/D complex in the cytoplasm (26, 27) . After the HlyA secretion signal binds to the HlyB/D complex, HlyD induces contact with TolC and the periplasmic end of the TolC tunnel is sealed by coiled coils and untwists when it makes contact with HlyD. Subsequently, HlyA enters TolC from HlyD via a continuous tunnel made by the HlyD-TolC complex. The binding and hydrolysis of ATP via HlyB are directly coupled to HlyA (9) .
Since the TolC proteins of E. coli and N. meningitidis are similar (22.4% identity), we asked if the N. meningitidis TolC protein could functionally replace the E. coli protein with respect to resistance to antimicrobials known to be recognized by the AcrA-AcrB-TolC efflux pump (5) and extracellular production of ␣-hemolysin by the HlyB-HlyD-TolC type I secretion system (27) . For this purpose, we introduced pGCC4 and pNK1 into E. coli strains MC4100 and RAM1129 (as MC4100 but TolC deficient). Using a rabbit anti-TolC antiserum (kindly provided by H. Zgurskaya, University of Oklahoma, Norman, OK) that cross-reacts with the meningococcal protein to identify TolC in Western immunoblots, we were able to detect the meningococcal TolC protein in whole-cell lysates from transformants of RAM1129 bearing pNK1 but not pGCC4 (data not presented). Importantly, we found that expression of the N. meningitidis tolC gene from pNK1 could endow strain RAM1129 with an antibiotic resistance phenotype similar to that of parental strain MC4100; however, RAM1129 with the pGCC4 vector remained hypersusceptible to the tested antimicrobials ( Table 2 ). Unlike that of N. meningitidis tolC, expression of the mtrE gene in E. coli RAM1129 failed to restore antimicrobial resistance (data not presented).
As a further test of the ability of the N. meningitidis TolC OMP to functionally replace the TolC protein produced by E. coli, we examined the alpha-hemolytic activity of the test strains because secretion of HlyA requires a functional HlyBHlyD-TolC efflux pump (28) . As is shown in Fig. 1 , we found that expression of the N. meningitidis tolC gene from pNK1, but not that of mtrE (data not presented), in nonhemolytic strain RAM1129 endowed it with an alpha-hemolytic phenotype similar to that of wild-type E. coli strain MC4100; RAM1129 with empty-vector pGCC4 remained nonhemolytic (Fig. 1) .
We conclude that the meningococcal TolC protein can func- tionally replace TolC of E. coli in two major export activities, efflux of antimicrobials and HlyA secretion. In contrast, when expressed in N. meningitidis, the same protein seems to function only in secretion of the FrpC protein, which has unknown biologic activity (4). Thus, although the MtrC-MtrD-MtrE efflux system possessed by N. gonorrhoeae and N. meningitidis is structurally and functionally similar to AcrA-AcrB-TolC of E. coli, the pumps have a preference for their respective OMPs, MtrE and TolC, used as a channel for extracellular export of antimicrobials. Our previous work with expression of the N. meningitidis tolC gene in strain M7 suggested that TolC produced by this pathogen was not involved in antimicrobial efflux, but our current work indicates that this protein has the intrinsic ability to work with AcrA-AcrB in drug efflux in an E. coli background. We suggest that this is due to differences between the AcrA-AcrB and MtrC-MtrD proteins that are involved in interacting with the OMP components (TolC versus MtrE) of tripartite efflux systems.
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